Pamela J. Cramer is CHRO at RHYTHM PHARMACEUTICALS, INC. (RYTM). They have made 3 open-market trades across 1 company since 2022, most recently 2026-02-01.
CIK 0001873517
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RYTM | SELL · 10b5-1 | 2025-12-11 | 2025-12-15 | $111.00 | $372K | -1.3% | +1.7% | -18.8% |
| RYTM | SELL · 10b5-1 | 2025-11-20 | 2025-11-24 | $105.00 | $352K | -4.0% | +3.1% | -11.5% |
| RYTM | SELL · 10b5-1 | 2025-11-07 | 2025-11-12 | $98.92 | $4.2M | +9.4% | +16.5% | +5.6% |
| RYTM | SELL · 10b5-1 | 2025-07-29 | 2025-07-29 | $85.93 | $261K | +5.7% | +19.8% | +28.2% |
| RYTM | SELL · 10b5-1 | 2025-07-09 | 2025-07-11 | $76.76 | $2.1M | +1.3% | +8.8% | +15.6% |
| RYTM | SELL · 10b5-1 | 2025-06-06 | 2025-06-10 | $68.05 | $957K | -7.5% | +32.6% | +48.6% |
| RYTM | SELL · 10b5-1 | 2025-04-29 | 2025-05-01 | $65.09 | $915K | -11.3% | -0.6% | +32.2% |
| RYTM | SELL · 10b5-1 | 2025-04-08 | 2025-04-10 | $59.72 | $1.6M | +3.6% | +2.1% | +54.1% |
| RYTM | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $57.22 | $112K | -9.4% | -10.0% | +10.5% |
| RYTM | SELL · 10b5-1 | 2025-02-11 | 2025-02-11 | $57.51 | $40K | -3.1% | -10.9% | +4.6% |
| RYTM | SELL | 2025-02-04 | 2025-02-04 | $59.43 | $107K | -6.2% | -14.5% | +6.6% |
| RYTM | SELL · 10b5-1 | 2024-11-06 | 2024-11-08 | $62.50 | $586K | -12.7% | -15.6% | -11.8% |
| RYTM | SELL · 10b5-1 | 2024-09-09 | 2024-09-11 | $50.03 | $410K | +4.0% | +1.5% | +17.6% |
| RYTM | SELL · 10b5-1 | 2024-08-26 | 2024-08-28 | $50.01 | $160K | +5.0% | +9.8% | +32.5% |
| RYTM | SELL · 10b5-1 | 2024-08-09 | 2024-08-13 | $45.15 | $4.4M | +1.3% | +8.3% | +44.0% |
| RYTM | SELL · 10b5-1 | 2024-07-29 | 2024-07-30 | $49.06 | $137K | -6.0% | -4.3% | +2.6% |
| RYTM | SELL | 2024-03-19 | 2024-03-19 | $39.22 | $1.2M | +9.9% | -1.9% | +6.0% |
| RYTM | SELL · 10b5-1 | 2024-02-12 | 2024-02-13 | $51.38 | $36K | -7.7% | -20.0% | -19.6% |
| RYTM | SELL · 10b5-1 | 2024-02-01 | 2024-02-05 | $45.06 | $43K | +10.0% | -10.5% | -4.4% |
| RYTM | SELL · 10b5-1 | 2023-07-26 | 2023-07-28 | $17.64 | $16K | +41.1% | +45.8% | +31.1% |
| RYTM | SELL · 10b5-1 | 2023-02-09 | 2023-02-14 | $27.51 | $23K | -8.7% | -33.2% | -37.5% |
| RYTM | SELL · 10b5-1 | 2023-02-09 | 2023-02-13 | $27.66 | $23K | -9.8% | -32.2% | -37.1% |
| RYTM | SELL | 2022-08-19 | 2022-08-23 | $24.83 | $670K | +8.2% | +3.2% | +0.0% |
| RYTM | SELL · 10b5-1 | 2022-07-27 | 2022-07-28 | $11.68 | $11K | +69.9% | +65.2% | +85.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.